all report title image

India Mucormycosis Treatment (Black Fungus Drugs) Market, By Species (Rhizopus, Cunninghamella, Rhizomucor, Saksenaea, Apophysomyces, Lichtheimia, Mucor, and Others), By Diagnosis Method (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Tissue Biopsy, and Others), By Drugs (Amphotericin B, Isavuconazole, Posaconazole, Voriconazole, Flucytosine, Fluconazole, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Geography (India)

  • Published In : 06 Jul, 2026
  • Code : CMI4444
  • Pages :259
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
  • 역사적 분포 범위 : 2020 - 2024
  • 기준 연도 : 2025
  • 예상 연도 : 2026
  • 예측 기간 : 2026 - 2033

Mucormycosis is a rapidly progressive and life-threatening invasive fungal disease with high morbidity and mortality rates despite treatment. It primarily affects immunocompromised patients such as those with organ and bone marrow transplantation, hematological malignancy, and patients with diabetes, cancer, neutropenia, and skin trauma. In rare cases it also affects immunocompetent patients. Mucormycosis is caused by a group of molds called mucormycetes. Inhaling the spores of the molds can affect the lungs and sinuses, and the fungus may also invade the skin through wounds such as cuts, burns, scrapes, or other types of skin trauma.

Market Dynamics

Major players in the market are indulged in inorganic activities such as collaborations with other market players, in order to launch anti-fungal drugs for the treatment of mucormycosis in the Indian population. This is expected to fuel growth of the India Mucormycosis Treatment (Black Fungus Drugs) market over the forecast period. For instance, on May 27, 2021, Strides Pharma Science Limited, a pharmaceutical company headquartered in Bangalore, India, are collaborating with TLC Pharma, a pharmaceutical company headquartered in Telangana, India, for launching TLC Pharma’s product AmphoTLC, a liposomal amphotericin B injection indicated for the treatment of various systemic fungal infections such as mucormycosis.

Different fungal species are involved for causing mucormycosis infection in Indian population. According to the article published in the Microorganism Journal, on March 4, 2021, the following graph shows the contribution of different species to mucormycosis burden in India (in percentage)

india-mucormycosis-treatment

Key features of the study

  • This report provides an in-depth analysis of India Mucormycosis Treatment (Black Fungus Drugs) market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the India Mucormycosis Treatment (Black Fungus Drugs) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences, Lyca Pharmaceuticals, Emcure Pharmaceuticals, Bharat Serums and Vaccines, BDR Pharmaceuticals, Cipla Limited, Lifecare Innovations, Synbiotics Limited, Kamla Lifesciences, Cadila Healthcare Limited, and TLC Pharma Labs
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The India Mucormycosis Treatment (Black Fungus Drugs) market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India Mucormycosis Treatment (Black Fungus Drugs) market

Market Segmentation

  • By Species (Revenue, USD Mn, 2021-2033)
    • Rhizopus
    • Cunninghamella
    • Rhizomucor
    • Saksenaea
    • Apophysomyces
    • Lichtheimia
    • Mucor
    • Others
  • By Diagnosis Method (Revenue, USD Mn, 2021-2033)
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Tissue Biopsy
    • Others
  • By Drugs (Revenue, USD Mn, 2021-2033)
    • Amphotericin B
    • Isavuconazole
    • Posaconazole
    • Voriconazole
    • Flucytosine
    • Fluconazole
    • Others
  • By Distribution Channel (Revenue, USD Mn, 2021-2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Key Players
    • Natco Pharmaceuticals
    • Alembic Pharmaceuticals
    • Gufic Biosciences
    • Lyca Pharmaceuticals
    • Emcure Pharmaceuticals
    • Bharat Serums and Vaccines
    • BDR Pharmaceuticals
    • Cipla Limited
    • Lifecare Innovations
    • Synbiotics Limited
    • Kamla Lifesciences
    • Cadila Healthcare Limited
    • TLC Pharma Labs

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Species
      • Market Snippet, By Diagnosis Method
      • Market Snippet, By Drugs
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Recent Product Launch/Approval
    • Epidemiology
    • Diagnosis and Treatment Overview
    • Competitive Intelligence
    • Prescription Pattern
    • Physicians Preferences and Views
  4. India Mucormycosis Treatment (Black Fungus Drugs) Market, By Species, 2021-2033 (USD Million)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Rhizopus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Cunninghamella
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Rhizomucor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Saksenaea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Apophysomyces
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Lichtheimia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Mucor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  5. India Mucormycosis Treatment (Black Fungus Drugs) Market, By Diagnosis Method, 2021-2033 (USD Million)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Magnetic Resonance Imaging (MRI)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Computed Tomography (CT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Tissue Biopsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  6. India Mucormycosis Treatment (Black Fungus Drugs) Market, By Drugs 2021-2033 (USD Million)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Amphotericin B
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Isavuconazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Posaconazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Voriconazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Flucytosine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Fluconazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  7. India Mucormycosis Treatment (Black Fungus Drugs) Market, By Distribution Channel, 2021-2033 (USD Million)
    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  8. Competitive Landscape
    • Company Profiles
      • Natco Pharmaceuticals
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Alembic Pharmaceuticals
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Gufic Biosciences
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Lyca Pharmaceuticals
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Emcure Pharmaceuticals
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Bharat Serums and Vaccines
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • BDR Pharmaceuticals
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Cipla Limited
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Lifecare Innovations
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Synbiotics Limited
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Kamla Lifesciences
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Cadila Healthcare Limited
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • TLC Pharma Labs
        • Company Overview
        • Drug Type Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.